Cite
MLA Citation
G. Garcia-Manero et al.. “100 INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH IPSS INTERMEDIATE-1 MYELODYSPLASTIC SYNDROMES WITH RBC-TRANSFUSION-DEPENDENT ANEMIA AND THROMBOCYTOPENIA: THE QUAZAR LOWER-RISK MDS TRIAL.” Leukemia research, vol. 39, no. 1, n.d., pp. S51–S52. http://access.bl.uk/ark:/81055/vdc_100059913122.0x000001